A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

Clinical trial NCT01564537 · COMPLETED

Trial details

NCT number: NCT01564537
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsed Multiple Myeloma Refractory Multiple Myeloma

Start date: 2012-08-01
Primary completion: 2014-10-01
Enrollment: 722

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.